why choose us

First received: February 24, 2023

Clinical Trial: Study of Dotatate Imaging in Breast Cancer

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Breast Cancer Stage IV

Study Type: INTERVENTIONAL


Official Title: Somatostatin Receptor Imaging Study of Estrogen Receptor Positive (ER+) Metastatic Breast Cancer

Brief Summary: This will be a Phase 2 clinical trial to assess somatostatin receptor (SSTR) expression in Stage IV estrogen receptor positive (ER+) breast cancer using Gallium-68 DOTATATE or Copper-64 DOTATATE PET/CT.

Read more